Award recordCONTRACT

INTERCEPT PHARMACEUTICALS INC

PIID VA797P16A0030· VA Staff Offices· NAC PHARMACEUTICALS 36P797· 6505 · DRUGS AND BIOLOGICALS· FY2017· $0 net obligations· UEI GHNKCLBJRMK7· NY

Description

BPA CANCELLATION

Base award description: BPA FOR OCALIVA

First action · last action
2016-10-17 · 2017-01-13
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$4,200,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D6029E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2016-10-17 · this action $0 · running total $0Modification P00001 · 2017-01-13 · this action $0 · running total $0
  • Base2016-10-17+$0= $0
  • Mod P000012017-01-13+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-17+$0$0BPA FOR OCALIVA
Mod P00001· LEGAL CONTRACT CANCELLATION2017-01-13+$0$0BPA CANCELLATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GHNKCLBJRMK7)

AwardOffice · PSC / listingNet obligationsFY
36E79725A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79724D0180NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36E79722A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36C24920F0531249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$49,147FY2020
36C24719K0039247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$4,363FY2019
36C26119F0005261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$26,401FY2019

Other recipients under 6505 from NAC PHARMACEUTICALS 36P797 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA797P17J0052MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$6,169FY2017
VA797P17J0051MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$17,881FY2017
VA797P17J0050MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$72,904FY2017
VA797P17J0048KREMERS URBAN PHARMACEUTICALS INC.NAC PHARMACEUTICALS 36P797$1,225,936FY2017
VA797P17J0053EXELAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$88,200FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P16A0030_3600 · retrieved 2026-09-26.